This white paper, curated and reviewed by
HITLAB, is an independent, evidence-based
report of the CERN Device , which is an
emerging therapeutic innovation in
women’s health. With HITLAB’s expertise in
digital health innovation, usability research,
medical devices value proposition, and
clinical validation, this paper assesses the
device’s safety, mechanism of action, and
potential clinical value in the management
of recurrent bacterial vaginosis (BV) and
vulvovaginal candidiasis (VVC) based on the
evidence studies conducted.
